Objective To explore the effect of mycoplasma pneumonia infection on pulmonary function in children with bronchial asthma,and provide objective basis for clinical treatment and prognosis assessment. Methods The clinical data of asthmatic children who were diagnosed and treated in our hospital from October 2013 to October 2015 were retrospectively analyzed.576 cases who have received pulmonary function test in the acute phase of treatment for one week were divided into two groups:positive group (asthma with mycoplasma pneumoniae infection group,144 cases)and negative group (asthma without mycoplasma pneumoniae infection,432 cases).Then the pulmonary ventilation function check indexes were analyzed by statistical software. Results 1)Comparison between negative group and positive group:about the lung ventilation function of two groups,positive group's forced vital capacity (FVC) was higher than that of negative group,the first second forced expiratory volume/forced vital capacity (FEV1 %) was lower than that of the negative group,and there was no statistically significant difference between them;Besides,first second forced expiratory volume (FEV1),peak expiratory flow (PEF) and maximal expiratory flow (MMEF) 25-75,PEF25,PEF50 in positive group were lower than those in negative group,and there were statistically significant differences (P<0.05),giving priority to MMEF 25-75.2)Comparision within positive group:children in the positive group were divide into the high titer group and the low titer group according to mycoplasma pneumoniae antibody titer.And there was no statistically significant difference between the two groups about the lung ventilation function (P>0.05). Conclusion Mycoplasma pneumoniae infection can reduce pulmonary function in children with asthma,giving priority to increasing the small airway obstructive pathological changes,so it is necessary to pay more attention to asthma children with mycoplasma pneumonia infection.
Key words
mycoplasma pneumonia /
bronchial asthma /
pulmonary function
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 尚云晓,冯雍.2014版全球哮喘防治创议(GINA)解读--与儿童哮喘相关内容[J].中国实用儿科杂志,2014,29(9):669-672.
[2] Darveaux JI,Lemanske RF.Infection-related asthma[J].J Allergy Clin Immunol Pract,2014,2(6):658-663.
[3] 张皓,邬宇芬,黄剑峰,等.儿童肺功能检测及评估专家共识[J].临床儿科杂志,2014,32(2):104-114.
[4] Koh YY,Park Y,Lee HJ,et al.Levels of interleukin-2,interferon-gamma,and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia:implication of tendency toward increased immunoglobulin E production[J].Pediatrics,2001,107(3):E39.
[5] 陈志敏.肺炎支原体肺炎的再认识--从发病机制到临床治疗的探讨[J].中国实用儿科杂志,2012,27(4):253-257.
[6] Lee KY.Pediatric respiratory infections by mycoplasma pneumoniae[J].Expert Rev Anti Infect Ther,2008,6(4):509-521.
[7] Prefontaine D,Hamid Q.Airway epithelial cells in asthma[J].J Allergy Clin Immunol,2007,120(6):1475-1478.
[8] Wang L,Chen Q,Shi C,et al.Changes of serum TNF-alpha,IL-5 and IgE levels in the patients of mycoplasma pneumonia infection with or without bronchial asthma[J].Int J Clin Exp Med,2015,8(3):3901-3906.
[9] Watanabe H,Uruma T,Nakamura H,et al.The role of mycoplasma pneumoniae infection in the initial onset and exacerbations of asthma[J].Allergy Asthma Proc,2014,35(3):204-210.